00068-7/asset/096c9be0-b6df-496c-ad71-95f35e424b2e/main.assets/gr2_lrg.jpg)
semaglutide and cirrhosis 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial glp 1 and liver cirrhosis
Description
While GLP-1s help you eat less and lose weight, NAD+ ensures your body continues to generate energy, recover, and think clearly
Frequency is not based on data from a head-to-head trial
Voor mensen met een verminderde nierfunctie kan uitdroging extra gevaarlijk zijn
10.1056/NEJMoa1509225 11
